Next-Generation mt-sDNA Test Beats FIT for Sensitivity

Source link :

A next-generation stool DNA test for colorectal cancer (CRC) screening had higher sensitivity for all screening-relevant lesions but lower specificity than a currently available fecal immunochemical test (FIT), according to the large prospective BLUE-C study. The multi-target assay by Exact Sciences Corporation, the makers of Cologuard, includes new biomarkers designed to increase specificity without decreasing […]

Author : News Health

Publish date : 2024-03-25 12:15:39

Copyright for syndicated content belongs to the linked Source.